296
Views
5
CrossRef citations to date
0
Altmetric
Review

The use of micro-electro mechanical systems in vascular monitoring: implications for clinical use

, , , , , & show all
Pages 831-837 | Received 20 Jan 2016, Accepted 27 Jun 2016, Published online: 03 Aug 2016

References

  • Bourassa MG. The history of cardiac catheterization. Can J Cardiol. 2005;21(12):1011–1014.
  • Schannwell CM, Steiner S, Strauer BE. Diagnostics in pulmonary hypertension. J Physiol Pharmacol. 2007;58Suppl 5(Pt 2):591–602.
  • Romagnoli S, Ricci Z, Quattrone D, et al. Accuracy of invasive arterial pressure monitoring in cardiovascular patients: an observational study. Crit Care;. 2014;18(6):644–655.
  • Adamson PB, Abraham WT, Bourge RC, et al. Wireless pulmonary artery pressure monitoring guide management to reduce decompensation in heart failure with preserved ejection fraction. Circ Heart Fail. 2014 Nov;7(6):935–944.
  • Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery hemodynamic monitoring in chronic heart failure: a randomized controlled trial. Lancet. 2011;377(9766):658–666.
  • Centuria SD. Microsystem design. Dordrecht: Kluwer; 2001. p. 570–577.
  • Madou M. Fundamentals of microfabrication. 2nd ed. Boca Raton, FL: CRC Press; 2002.
  • Jackson M. Microfabrication and manufacturing. Boca Raton, FL: CRC Press; 2007.
  • Bashir R. BioMEMS: state-of- the- art in detection, opportunities’ and prospects. Adv Drug Delivery Rev. 2004;56(11):1565–1586.
  • Pan JY. Reliability considerations for the BioMEMS designer. Proc IEEE. 2004;92(1):174–184.
  • Saliterman SS. Fundamentals of BioMEMS and medical microdevices. Hoboken, NJ: Wiley; 2005.
  • James T, Manoor MS, Ivanov DV. BioMEMS, advancing the frontiers of medicine. Sensors. 2008;8:6077–6107.
  • Hag H, Esaschi M. Biomedical microsystems for minimally invasive diagnosis and treatment. Proc. IEEE. 2004;92(1):98–114.
  • Marks RS, Cullen DS, Karube I, et al. Handbook of biosensors and biochips. Vol. 2. Hoboken, NJ: Wiley; 2007; p. 757–777.
  • Folch A. Introduction to bio-MEMS. Various pagings. Boca Raton: CRC Press; 2013.
  • Jiang G. Design challenges for implantable pressure monitoring system. Front Neurosci. 2010;4(29):1–4.
  • Alvin Barlian A, Park W-T, Mallon JR, et al. Review: semiconductor piezoresistance for microsystems. Proc IEEE Inst Electr Electron Eng. 2009;97(3):513–552.
  • Starra P, Bartelsc K, Agrawalb M, et al. Evolution of micromachined pressure transducerrs for cardiovascular applications. Sensors Actuators A: Physical. 2015;225(225):8–19.
  • Yuan QY, Zhang L, Xiao D, et al. An accurate, flexible and small optical fiber sensor: a novel technological breakthrough for real-time analysis of dynamic blood flow data in vivo. PLoS One. 2014;9(12):e114794.
  • Yu H, Huang J. Design and application of a high sensitivity piezoresistive pressure sensor for low pressure conditions. Sensors (Basel). 2015;15(9):22692–22704.
  • O’Neal CB, Malshe AP, Singh SB, et al. “Challenges in the packaging of MEMS,” in advanced packaging materials: processes, properties and interfaces. Proc Int Symp. 1999;22:41–47.
  • Clausen I, Glott T. Development of clinically relevant implantable pressure sensors: perspectives and challenges. Sensors (Basel). 2014;14(9):17686–17702.
  • Kalvesten E, Smith L, Tenerz L, et al. The first surface micromachined pressure sensor for cardiovascular pressure measurements. In: MEMS 98. proceedings., The eleventh annual international workshop on Micro electro mechanical systems. Heidelberg: IEEE; 1998 Jan 25–29; p. 574–579.
  • Kristo B, Liao JC, Neves HP, et al. Microelectromechanical systems in urology. Urology. 2003;61(5):883–887.
  • Kim S, Roy S. Microelectromechanical systems and nephrology: the next frontier in renal replacement technology. Adv Chronic Kidney Dis. 2013;20(6):516–535.
  • Am K, Rolett EL. Heart failure: when form fails to follow function. Eur Heart J. 2015 Oct 24:449–454. pii: ehv548.
  • Genet M, Lee LC, Baillargeon B, et al. Modeling pathologies of diastolic and systolic heart failure. Ann Biomed Eng. 2016;44(1):112–127.
  • Padhukasahasram B, Reddy CK, Li Y, et al. Joint impact of clinical and behavioral variables on the risk of unplanned readmission and death after a heart failure hospitalization. PLoS One. 2015;10(6):e012955.
  • McMurray JJ. Clinical practice. Systolic heart failure. N Engl J Med. 2010;362(3):228–238.
  • Krahnke JS, Abraham WT, Adamson PB, et al. Heart failure and respiratory hospitalizations are reduced in patients with heart failure and chronic obstructive pulmonary disease with the use of an implantable pulmonary artery pressure monitoring device. J Card Fail. 2015;21(3):240–249.
  • Ciccone MM, Aquilino A, Cortese F, et al. Feasibility and effectiveness of a disease and care management model in the primary health care system for patients with heart failure and diabetes(Project Leonardo). Vasc Health Risk Manag. 2010;6:297–305.
  • Abraham WT. Disease management: remote monitoring in heart failure patients with implantable defibrillators, resynchronization devices, and hemodynamic monitors. Europace. 2013;15(Suppl 1):i40–i46.
  • Abraham WT, Adamson PB, Bourge RC, et al. CHAMPION Trial Study Group. Wireless pulmonary artery haemodynamicmonitoring in chronic heart failure: a randomized controlled trial. Lancet. 2011;377(9766):658–666.
  • Adamson PUB, Abraham WT, Aaron M, et al. CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system. J Card Fail. 2011;17(1):3–10.
  • Loh JP, Barbash IM, Waksman R. Overview of the 2011 food and drug administration circulatory system devices panel of the medical devices advisory committee meeting on the CardioMEMS champion heart failure monitoring system. JAm Coll Cardiol. 2013;61(15):1571–1576.
  • CardioMEMS HF system. [cited 2016 Jan 18]. Available from: http://www.sjm.com/cardiomems.
  • William T, Philip A, Robert B, et al. Wireless pulmonary artery hemodynamic monitoring in chronic heart failure: a randomized controlled trial. The Lancet. 2011;377(9766):658–666.
  • Costanzo MR, Stevenson LW, Adamson P, et al. Interventions linked to decreased heart failure hospitalizations during ambulatory pulmonary artery pressure monitoring. JACC Heart Fail. 2016 May;4(5):333–344. pii: S2213-1779(15)00782-9.
  • Sandhu AT, Goldhaber-Fiebert JD, Owens DK, et al. Cost-effectiveness of implantable pulmonary artery pressure monitoring in chronic heart failure. JCHF. 2016;4(5):368–375. pii: S2213-1779(15)00838-0.
  • Kuivaniemi H, Chris D, Platsoucas, M, et al. Aortic aneursyms.An immune disease with a strong genetic component. Circulation. 2008;117:242–252.
  • Milner R, De Rango P, Verzini F, et al. Are intrasac pressure measurements useful after endovascular repair of abdominal aortic aneurysms? J Vasc Surg. 2011;53(2):534–539.
  • Hrikhande G, Khan S, Hussain H, et al. Significance of initial aortic aneurysm pressure sensor readings varies with aortic endograft design. World J Surg. 2010;34(12):2969–2972.
  • Louwers LM, Seder CW, Bove PG. A novel treatment approach to a type IIendoleak at endograft implantation using components of an endosensor monitoring device. Vasc Endovascular Surg. 2010;44(7):568–571.
  • Parsa CJ, Daneshmand MA, Lima B, et al. Utility ofremote wireless pressure sensing for endovascular leak detection after endovascular thoracic aneurysm repair. Ann Thorac Surg. 2010;89(2):446–452.
  • Silveira PG, Miller CW, Mendes RF, et al. Correlation between intrasacpressure measurements of a pressure sensor and an angiographic catheter during endovascular repair of abdominal aortic aneurysm. Clinics. 2008;63(1):59–66.
  • Hoppe H, Segall JA, Liem TK, et al. Aortic aneurysm sac pressure measurements after endovascular repair using an implantable remote sensor: initial experience and short-term follow-up. Eur Radiol. 2008 May;18(5):957–965.
  • Bakris GL, Nadim MK, Haller H, et al. Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial. J Am Soc. 2012;6(2):152–158.
  • Hoppe UC, Brandt MC, Wachter R, et al. Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trail. J Am Soc Hypertens. 2012;6(4):270–276.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.